LEADER 02342oam  2200625   450 
001 9910716651603321
005 20211215140110.0
024 8 $a44-686
035   $a(CKB)5470000002523650
035   $a(OCoLC)1259692367
035   $a(EXLCZ)995470000002523650
100   $a20210712d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExamining Emergent Biosolutions' failure to protect public health and public funds $ehearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021
210  1$aWashington :$cU.S. Government Publishing Office,$d2021.
215   $a1 online resource (iii, 44 pages)
300   $aAccess ID (govinfo): CHRG-117hhrg44686.
300   $a"Serial no. 117-23."
517   $aExamining Emergent Biosolutions' failure to protect public health and public funds 
606   $aCOVID-19 (Disease)$xVaccination$zUnited States
606   $aCOVID-19 Pandemic, 2020-$zUnited States
606   $aVaccines industry$xGovernment policy$zUnited States
606   $aVaccines industry$xSubsidies$zUnited States
606   $aVaccines$zUnited States
606   $aCOVID-19 (Disease)$xVaccination$2fast
606   $aVaccines industry$xGovernment policy$2fast
606   $aVaccines industry$xSubsidies$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2fast
608   $aLegislative hearings.$2lcgft
615  0$aCOVID-19 (Disease)$xVaccination
615  0$aCOVID-19 Pandemic, 2020-
615  0$aVaccines industry$xGovernment policy
615  0$aVaccines industry$xSubsidies
615  0$aVaccines
615  7$aCOVID-19 (Disease)$xVaccination.
615  7$aVaccines industry$xGovernment policy.
615  7$aVaccines industry$xSubsidies.
676   $a4.OV 2:117-23
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCO
801  2$bOCLCF
801  2$bOCLCQ
801  2$bDWP
801  2$bGPO
906   $aBOOK
912   $a9910716651603321
996   $aExamining Emergent Biosolutions' failure to protect public health and public funds$93498239
997   $aUNINA